Innovation Pharmaceuticals (OTCMKTS:IPIX) Stock Price Down 11.8%

Innovation Pharmaceuticals Inc (OTCMKTS:IPIX)’s share price dropped 11.8% during mid-day trading on Monday . The company traded as low as $0.15 and last traded at $0.15, approximately 473,705 shares changed hands during trading. A decline of 7% from the average daily volume of 510,674 shares. The stock had previously closed at $0.17.

The firm has a fifty day simple moving average of $0.18.

About Innovation Pharmaceuticals (OTCMKTS:IPIX)

Innovation Pharmaceuticals Inc, a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. The company's lead drug compound is Brilacidin, which is in Phase II study for the treatment of oral mucositis, inflammatory bowel disease, and acute bacterial skin and skin structure infection.

Featured Story: Bollinger Bands

Receive News & Ratings for Innovation Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovation Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.